(Q40394357)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

Human Induced Pluripotent Stem Cells

28 February 2020

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jose Carlos Segovia

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

José L Sardina

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Álvaro Muñoz López

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

M. Carmen Chillón

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Agustin F. Fernandez

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Mahito Nakanishi

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Pablo Menendez

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

C Bueno

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

D Romero-Moya

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

L Ariza

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

A Balanzategui

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

J Castaño

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

A Herreros

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

M F Fraga

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

I Granada

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

O Quintana-Bustamante

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

K Nishimura

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

M Ohtaka

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

T Graf

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

26 October 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

674-682

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

Harnessing the potential of induced pluripotent stem cells for regenerative medicine

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Generation of induced pluripotent stem cells from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Reprogramming of human peripheral blood cells to induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Recombinant Sendai virus vectors for activated T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Fast and efficient neural conversion of human hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Cancer genes hypermethylated in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

The Notch ligand DLL4 specifically marks human hematoendothelial progenitors and regulates their hematopoietic fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

HOXA9 promotes hematopoietic commitment of human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

The role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Human induced pluripotent stem cell-derived B lymphocytes express sIgM and can be generated via a hemogenic endothelium intermediate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

T-cell antigen receptor genes and T-cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Induced pluripotent stem cells: epigenetic memories and practical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

PI3 kinase signals BCR-dependent mature B cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

CCAAT/enhancer binding protein alpha (C/EBP(alpha))-induced transdifferentiation of pre-B cells into macrophages involves no overt retrodifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.294

Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

12 December 2020

Molecular characteristics and gene segment usage in IGH gene rearrangements in multiple myeloma.

1 reference

12 December 2020

Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential

1 reference

12 December 2020

Development and selection of T cells: facts and puzzles

1 reference

12 December 2020

Maintenance of human embryonic stem cells in media conditioned by human mesenchymal stem cells obviates the requirement of exogenous basic fibroblast growth factor supplementation

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2015.294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

28 February 2020

1052804202

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26500142%20AND%20SRC:MED&resulttype=core&format=json